Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Use of CMV Immunoglobulin in High Risk (D+R-) Transplant Recipients at the End of Antiviral Prophylaxis to Decrease the Risk of Late CMV Infection

NCT06958796 is registered in ClinicalTrials.gov with Camille N. Kotton, MD as lead sponsor.

NCT NCT06958796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06958796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Use of CMV Immunoglobulin in High Risk (D+R-) Transplant Recipients at the End of Antiviral Prophylaxis to Decrease the Risk of Late CMV Infection
Lead sponsor
Camille N. Kotton, MD
Phase
Phase 4
Overall status
Recruiting
Start date
November 27, 2025
Completion date
May 31, 2028
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus, kidney transplant; complications, liver transplant complications, organ transplant, simultaneous liver-kidney transplantation; complications